Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Ly108 expression distinguishes subsets of invariant NKT cells that help autoantibody production and secrete IL-21 from those that secrete IL-17 in lupus prone NZB/W mice.

Tang X, Zhang B, Jarrell JA, Price JV, Dai H, Utz PJ, Strober S.

J Autoimmun. 2014 May;50:87-98. doi: 10.1016/j.jaut.2014.01.002. Epub 2014 Feb 7.

3.

Beta-galactosylceramide alters invariant natural killer T cell function and is effective treatment for lupus.

Morshed SR, Takahashi T, Savage PB, Kambham N, Strober S.

Clin Immunol. 2009 Sep;132(3):321-33. doi: 10.1016/j.clim.2009.05.018. Epub 2009 Jun 28.

4.

Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production.

Shen L, Zhang H, Caimol M, Benike CJ, Chakravarty EF, Strober S, Engleman EG.

Eur J Immunol. 2015 Feb;45(2):612-23. doi: 10.1002/eji.201444760. Epub 2014 Nov 27.

5.

Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells.

Sobel ES, Morel L, Baert R, Mohan C, Schiffenbauer J, Wakeland EK.

J Immunol. 2002 Oct 1;169(7):4025-32.

6.

An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.

Wellmann U, Letz M, Schneider A, Amann K, Winkler TH.

Int Immunol. 2001 Dec;13(12):1461-9.

PMID:
11717187
7.

Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.

Godó M, Sessler T, Hamar P.

Curr Med Chem. 2008;15(18):1778-87. Review.

PMID:
18691038
8.

Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity.

Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, Tamaki K, Sato S, Tedder TF, Fujimoto M.

J Immunol. 2010 May 1;184(9):4801-9. doi: 10.4049/jimmunol.0902385. Epub 2010 Apr 5.

9.

IL-10 Production Is Critical for Sustaining the Expansion of CD5+ B and NKT Cells and Restraining Autoantibody Production in Congenic Lupus-Prone Mice.

Baglaenko Y, Manion KP, Chang NH, Gracey E, Loh C, Wither JE.

PLoS One. 2016 Mar 10;11(3):e0150515. doi: 10.1371/journal.pone.0150515. eCollection 2016.

10.
11.

Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF/BLyS production.

Postól E, Meyer A, Cardillo F, de Alencar R, Pessina D, Nihei J, Mariano M, Mengel J.

Immunology. 2008 Oct;125(2):184-96. doi: 10.1111/j.1365-2567.2008.02835.x. Epub 2008 Apr 7.

12.
13.

Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner.

Yang JQ, Wen X, Kim PJ, Singh RR.

J Immunol. 2011 Feb 1;186(3):1512-20. doi: 10.4049/jimmunol.1002373. Epub 2011 Jan 5.

14.
15.

Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.

Yang JQ, Wen X, Liu H, Folayan G, Dong X, Zhou M, Van Kaer L, Singh RR.

Arthritis Rheum. 2007 Apr;56(4):1219-33.

16.

Epistatic suppression of fatal autoimmunity in New Zealand black bicongenic mice.

Loh C, Pau E, Lajoie G, Li TT, Baglaenko Y, Cheung YH, Chang NH, Wither JE.

J Immunol. 2011 May 15;186(10):5845-53. doi: 10.4049/jimmunol.1003426. Epub 2011 Apr 4.

17.

Differential sensitivity to interleukins of CD5+ and CD5- anti-DNA antibody-producing B cells in murine lupus.

Kanno K, Okada T, Abe M, Hirose S, Shirai T.

Autoimmunity. 1993;14(3):205-14.

PMID:
7687154
18.

Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice.

Nakajima A, Hirose S, Yagita H, Okumura K.

J Immunol. 1997 Feb 1;158(3):1466-72.

PMID:
9013993
19.

Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.

Forestier C, Molano A, Im JS, Dutronc Y, Diamond B, Davidson A, Illarionov PA, Besra GS, Porcelli SA.

J Immunol. 2005 Jul 15;175(2):763-70.

20.

Supplemental Content

Support Center